Elixherb Pharmaceutical Llp - Company Profile

It is a pharma limited liability partnership based in Kolhapur, Maharashtra, India, established in 2017.
2017 Kolhapur, Maharashtra, India Active
Last Updated:
Access Report
About Elixherb Pharmaceutical Llp

Elixherb Pharmaceutical Llp, a active limited liability partnership, was established on 18 April 2017 in Kolhapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAJ-1785. Registered under ROC Roc Pune. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Jeevan Vasantrao Shirgaokar (Designated Partner), Raj Kantilal Patel (Designated Partner), Dhiraj Maruti Patil (Designated Partner). Its latest date of accounts and solvency statement 31 March 2023. It is based at 1182/127 Bl. No. 9 Amey Co-Operative Housing Society, Mali, Colony,, Kolhapur, Maharashtra, 416008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAJ-1785

  • Incorporation Date

    18 April 2017

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Elixherb Pharmaceutical Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elixherb Pharmaceutical Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elixherb Pharmaceutical Llp?
Current Designated Partners
Name Designation Appointment Date Status
Jeevan Vasantrao Shirgaokar Designated Partner 18 Apr 2017 Current
Raj Kantilal Patel Designated Partner 18 Apr 2017 Current
Dhiraj Maruti Patil Designated Partner 18 Apr 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elixherb Pharmaceutical Llp.

Enhance accessibility to Elixherb Pharmaceutical Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Elixherb Pharmaceutical Llp revenue growth over time
Elixherb Pharmaceutical Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elixherb Pharmaceutical Llp?

Unlock access to Elixherb Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elixherb Pharmaceutical Llp?

Unlock and access historical data on people associated with Elixherb Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elixherb Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixherb Pharmaceutical Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elixherb Pharmaceutical Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Elixherb Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Elixherb Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Progress on Jeevan Vasantrao Shirgaokar was appointed as a Designated Partner was appointed as a Designated Partner on 18 Apr 2017 & has been associated with this company since 8 years 9 months . was documented.

  • Director Appointment

    Raj Kantilal Patel was appointed as a Designated Partner was appointed as a Designated Partner on 18 Apr 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Dhiraj Maruti Patil was appointed as a Designated Partner was appointed as a Designated Partner on 18 Apr 2017 & has been associated with this company since 8 years 9 months . was completed.

  • LLP Incorporation

    Elixherb Pharmaceutical Llp was registered on 18 Apr 2017 with Roc Pune & aged 8 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Elixherb Pharmaceutical Llp?

The LLPIN of Elixherb Pharmaceutical Llp is AAJ-1785.

Where is Elixherb Pharmaceutical Llp headquartered?

Elixherb Pharmaceutical Llp is headquartered at 1182/127 Bl. No. 9 Amey Co-Operative Housing Society, Mali, Colony,, Kolhapur, Maharashtra, 416008.

When was Elixherb Pharmaceutical Llp incorporated?

Elixherb Pharmaceutical Llp was incorporated on 18 April 2017.

Who are the current directors of Elixherb Pharmaceutical Llp?

The current directors of Elixherb Pharmaceutical Llp are

What is the primary industry of Elixherb Pharmaceutical Llp?

The primary industry of Elixherb Pharmaceutical Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available